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A B S T R A C T
Background: First described by John Nottingham in 1857, geniculate neuralgia remains a rare condition asso-
ciated with vascular compression of the nervus intermedius by the anterior inferior cerebellar artery (AICA),
which results in paroxysmal unilateral periauricular pain. Furthermore, limited and controversial treatment
options for symptom relief exist given the rarity of the condition and limited cases reported in the literature.
Case description: This is a case of a 37-year-old one-pack-per-day smoker with diabetes mellitus who presented to
our clinic for evaluation of episodic lancinating pain localizing to the right periauricular region. The patients
symptoms were attempted to be managed medically, however, remained refractory to medical management for a
period greater than one year. The patient’s exam demonstrated a trigger point slightly anterior and inferior to the
right tragus, and the pain was reproducible when touched or tapped. The patient was otherwise neurologically
intact. Magnetic resonance imaging (MRI) was performed and demonstrated a loop of the AICA in contact with
the root entry zone of the facial nerve. This patient was offered an elective microvascular decompression (MVD)
for treatment of geniculate neuralgia.
Conclusions: Surgical microvascular decompression is a safe and effective treatment option for patients suffering
from neuralgia refractory to medical therapy. Furthermore, our case report demonstrates that MVD is an ef-
fective treatment option for patients suffering from geniculate neuralgia with imaging evidence of AICA com-
pression of the nervus intermedius that is refractory to medical management.
1. Introduction
Geniculate neuralgia, also referred to as nervus intermedius neur-
algia or Hunt’s neuralgia, is a rare condition first described in 1857 by
John Nottingham, with fewer than 150 cases reported in the literature
from 1932 through 2012 [1–3]. Geniculate neuralgia is a condition
most commonly described by its association with herpes zoster or
vascular compression of the nervus intermedius, a small branch of the
facial nerve, frequently by the anterior inferior cerebellar artery
(AICA). The nervus intermedius, also referred to as the intermediate
nerve of Wrisberg, was first identified in 1563 [1,2]. However, it was
not documented in the literature until 1777 by Heinrich August Wris-
berg at the German University of Göttingen, describing it as the “portio
media inter comunicantem faciei et nervum auditorium.” [1,2] (Table 1).
John Nottingham first described the clinical features of geniculate
neuralgia as paroxysmal flushing and pain of the ear in 1857, char-
acterizing it as “tic douloureux of the ear” [1,2,4]. However, it was not
until 1907 when James Ramsay Hunt identified the correlation between
tic douloureux of the ear and the nervus intermedius from his work
with herpes zoster oticus, coining the term geniculate neuralgia [1,2,4].
Currently, the International Headache Society describes the diagnostic
criteria for geniculate neuralgia as paroxysmal unilateral periauricular
shooting or stabbing pain that lasts a few seconds to minutes, is severe
in intensity, and is exacerbated by a trigger point within the distribu-
tion of the nervus intermedius [5].
Anatomically and functionally, the nervus intermedius contains
sensory fibers, parasympathetic secretory fibers, and special cutaneous
afferent sensory fibers. The parasympathetic fibers are derived from the
superior salivary nucleus of the facial nerve located in the dorsal pons,
which travel to innervate the submandibular, sublingual, and lacrimal
glands [2,6]. Somatosensory components of the nervus intermedius are
branches of the facial nerve located within the geniculate ganglion,
carrying cutaneous sensorium input from the external auditory meatus,
the cymba, and cavum of the external ear [2,7]. The nervus intermedius
is also composed of special afferent fibers from the gustatory nucleus,
relaying taste from the anterior two-thirds of the tongue, the palate, and
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floor of the oral cavity [2,6,7,8].
Definitive diagnosis of geniculate neuralgia remains complex due to
contributions of the vagus, glossopharyngeal, trigeminal nerve, as well
as the nervus intermedius [2,6,7]. Yet, multiple treatment approaches
continue to be developed and refined in an effort to treat this rare
condition. The following describes a case of geniculate neuralgia that
was successfully treated with microvascular decompression (MVD) of
the nervus intermedius.
2. Case report
2.1. History of presenting illness
A 37-year-old one-pack-per-day smoker with diabetes mellitus pre-
sented to our neurosurgical clinic for evaluation of episodic lancinating
pain localizing to the right periauricular region. The patient reported
experiencing approximately three attacks of ear pain per day that were
refractory to medical management over a period greater than one year
with failed trials of amitriptyline, carbamazepine, gabapentin, baclofen,
meclizine, and meloxicam. The pain originated from the right tragus
and radiated to the deep facial structures and the ipsilateral eye. The
pain distribution did not fit that of classical trigeminal neuralgia.
2.2. Physical examination and diagnostic imaging
On the preoperative neurological exam, the patient was alert and
oriented to person, place, and time. Pupils were three millimeters and
reactive with intact extraocular movements. The patient’s hearing was
intact bilaterally, with no other cranial nerve deficits detected on exam.
A trigger point slightly anterior and inferior to the right tragus would
reproduce the pain when touched or tapped. No pronator drift was
detected and strength and sensation were full and intact in all ex-
tremities. Magnetic resonance imaging (MRI) was performed and de-
monstrated a loop of the AICA in contact with the root entry zone of the
facial nerve (Fig. 1). As the patient met the diagnostic criteria for
geniculate neuralgia, he was offered elective intervention for sympto-
matic control, and was ultimately consented for MVD of the nervus
intermedius via a right retrosigmoid cranial approach.
2.3. Operative details
Preoperatively, the patient was placed in the lateral decubitus po-
sition for lumbar drain insertion. The patient was then repositioned
supine on a standard operative table and placed in the Mayfield clamp.
An ipsilateral shoulder and hip bump were placed to facilitate the po-
sitioning of the right mastoid at the apex of the operating field. The
patient’s retrosigmoid scalp was shaved, and anatomical landmarks
were used to delineate the junction of the transverse and sigmoid sinus.
A standard linear incision was planned one-third above the transverse
sinus and two-thirds below. The patient was then prepped and draped
in the usual sterile fashion. Neuromonitoring was utilized throughout
the procedure to monitor the function of the facial nerve, as well as
brainstem auditory evoked responses (BAER).
A right retrosigmoid craniotomy was performed. The transverse and
sigmoid sinuses were identified and a curvi-linear dural incision was
made. Tack-up sutures were placed along the dural edge to increase the
visual field. The lumbar drain was opened and 15ml of cerebral spinal
fluid (CSF) was evacuated for relaxation of the retrosigmoid corridor.
Additionally, the patient was hyperventilated to a pCO2 of 25mmHg
and 100 g of intravenous mannitol was delivered.
Cottonoid® patties were placed over the cerebellar hemisphere as a
retractor-free approach along the right retrosigmoid corridor and was
conducted with the aid of microscissors to facilitate sharp dissection.
The lower cranial nerves were identified and dissection superiorly re-
vealed the vestibulocochlear and facial nerve complex. After meticulous
dissection of the arachnoid, it became apparent that AICA did not form
a classical loop. Instead, the offending artery passed between the facial
and cochlear nerve and imbedded into the root entry zone. Electrical
stimulation confirmed the identity of the facial nerve. A fixed retractor
was placed with the Budde halo and gentle dissection provided a plane
between the brainstem and AICA. A small Teflon pledget was placed in
this space to protect the root entry zone. Further mobilization AICA
from the nerves was attempted but limited because manipulation of the
nerves began to corelate with increased latencies of the BAERs. The
facial nerve was stimulated again and its function confirmed with a
stimulus of < 0.05mA. No effort was made to isolate and ligate the
nervus intermedius. Finally, more Teflon pledgets were placed cir-
cumferentially around AICA and secured using fibrin sealant (Tisseel,
Baxter International Inc., Deerfield, IL, USA).
Following hemostasis and irrigation, the dura was closed in a wa-
tertight fashion. A 2-inch× 2-inch synthetic dural repair material
(DuraGen, Integra Lifesciences, Plainsboro, NJ, USA) was placed over
the site of durotomy. The cranial flap was plated with titanium brackets
and secured with screws. The nuchal muscles, dermis, and skin were
then reapproximated using interrupted sutures in a multilayer fashion.
The patient was awakened without event and observed overnight in the
intensive care unit. The lumbar drain was left in place post-operatively,
with intermittent drainage of 10ml/h. It was clamped after 24 h and
removed on post-operative day two.
3. Results
On post-operative day 1, the patient’s facial pain had completely
resolved. All cranial nerves were functioning at the pre-operative
baseline activity. Touching or tapping the trigger point did not elicit
any pain. Patient was seen in clinic 4 weeks post-operative and con-
tinued to be pain free. At 5months post-operatively, patient continues
to report 60% pain control compared to pre-operative pain levels.
Follow-up MRI demonstrated separation of the vessel loop from the
nervus intermedius (Fig. 2).
4. Discussion
Geniculate neuralgia remains a clinically challenging entity sec-
ondary to the rarity of the disorder, the complexity of diagnosis, the
Fig. 1. Axial T2 weighted magnetic resonance image demonstrating AICA
compression at the root entry zone of the facial nerve (arrow).
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frequency of failed medical management, and the technical skill re-
quired to negotiate the operative nuance. However, continued re-
porting of these rare cases, in addition to further technological ad-
vances in MR imaging have made the diagnosis more reliable and
familiar. Burmeister et al. reported a novel way of identifying the
nervus intermedius in 2011 through high-field 3 T MRI that was not
previously possible using CT or 1.5 T MRI [9]. The authors reportedly
evaluated 54 nervus intermedi in 27 healthy volunteers and were able
to identify bilateral facial nerve branches in 57.4% of cases, and at least
one nervus intermedius in 70.4% of individuals [9].
There is a lack of evidence for a definitive management algorithm
for geniculate neuralgia. Although it is generally accepted that medical
management should be trialed prior to operative intervention, a su-
perior first-line medication has not been identified. The most common
techniques for surgical management of geniculate neuralgia remain
nervus intermedius sectioning, geniculate ganglion excision, and mi-
crovascular decompression [2,3,6,8]. Accessing the nervus intermedius
for operative intervention can be limited in up to 20% of cases as the
intracisternal portion of the nerve remains adherent to the superior
vestibular nerve and does not separate until within the internal acoustic
meatus, making identification virtually impossible intraoperatively
[8,10]. When identifiable, the nervus intermedius is often in close
proximity to and between the facial nerve and superior portion of the
vestibular nerve, making it challenging to surgically manipulate [8].
Pulec et al. described the outcomes of 64 patients that underwent
sectioning of the nervus intermedius and excision of the geniculate
ganglion through a middle cranial fossa approach [11]. The in-
vestigators determined that this technique was safe and effective for
treatment of geniculate neuralgia refractory to conservative manage-
ment. The report documented only a single case of facial paralysis that
ultimately recovered [11].
Rupa et al. described 18 cases of primary otalgia over a 15-year
period that were treated with four different operative procedures based
on presumed etiology: tympanotomy for chorda tympani and tympanic
nerve section, the technique described by Pulec utilizing a middle
cranial fossa approach for geniculate ganglionectomy, posterior cranial
fossa approach for nervus intermedius, ninth, and tenth cranial nerve
sectioning, and a combination of the posterior and middle fossa ap-
proach for nervus intermedius and fifth, ninth, and tenth nerve
exposure with geniculate ganglionectomy [12]. They demonstrated a
total success rate of 72.2%, with increased pain relief in patients that
had sectioning of the seventh nerve (geniculate ganglion, nervus in-
termedius, and chorda tympani), ninth, tympanic nerve, and the upper
rootlets of the tenth nerve [12].
More recently, Peris-Celda et al. reported a retrospective review of
11 patients treated for geniculate neuralgia (nine primary, two re-
operative) from 2000 to 2017 [13]. The authors describe nine patients
who were treated with sectioning of the nervus intermedius, and two
who underwent microvascular decompression [13]. Of the two patients
treated with MVD, one had complete resolution of their pain post-op-
eratively and no longer required neuropathic pain medications,
whereas the second had improved, but experienced incomplete re-
solution of pain and remained on neuropathic pain medication [13].
Saers et al. reported a case of geniculate neuralgia in a 24-year-old
female in 2011 who was successfully treated with MVD after de-
termining neurovascular compression of the nervus intermedius by the
AICA on fast imaging employing steady-state acquisition (FIESTA) MRI
[14]. The authors reported complete resolution of pain immediately
post-operatively and at one year follow-up without complication [14].
The goal of this report is to increase the awareness geniculate neuralgia
and to demonstrate MVD is an effective technique to achieve sympto-
matic relief in patients refractory to medical management. To date, our
patient continues to report satisfactory pain control.
5. Conclusion
Geniculate neuralgia is a rare disorder that is clinically challenging
to diagnose. Definitive medical and surgical treatments have yet to be
clearly elucidated. Furthermore, prospective studies to determine the
outcomes and complications following nervus intermedius sectioning
with geniculate ganglion excision versus microvascular decompression
appear unlikely for this infrequent disease. This report demonstrates
that nervus intermedius MVD is an effective technique for those pa-
tients with imaging evidence of AICA compression that is refractory to
medical management.
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